We are live on
!
Find out more
Alyeska Investment Group Portfolio holdings
AUM
$35.4B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$25.1B
AUM Growth
-$1.52B
(-5.7%)
Cap. Flow
-$491M
Cap. Flow
% of AUM
-1.96%
Top 10 Holdings %
Top 10 Hldgs %
22.13%
Holding
697
New
161
Increased
139
Reduced
161
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$563M |
| 2 |
Microsoft
MSFT
|
+$408M |
| 3 |
Salesforce
CRM
|
+$308M |
| 4 |
EA
Electronic Arts
EA
|
+$210M |
| 5 |
Wayfair
W
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$876M |
| 2 |
Meta Platforms (Facebook)
META
|
+$445M |
| 3 |
Alibaba
BABA
|
+$417M |
| 4 |
Boeing
BA
|
+$333M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.42% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Healthcare | 10.34% |
| 4 | Industrials | 10.11% |
| 5 | Real Estate | 7.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
P3 Health Partners
PIII
$42.7M
| $1.48M | 0.01% |
180,907
-57,212
| -24% | -$564K |
|
|
CBLL
427
CeriBell Inc
CBLL
$732M
| $1.44M | 0.01% |
75,000
-50,000
| -40% | -$1.11M |
|
|
MAZE
428
Maze Therapeutics
MAZE
$1.51B
| $1.38M | 0.01% |
+125,000
| New | +$1.5M |
|
429
Novartis
NVS
$298B
| $1.31M | 0.01% |
+11,722
| New | +$1.25M |
|
430
Lincoln Electric
LECO
$15.1B
| $1.2M | ﹤0.01% |
+6,340
| New | +$1.24M |
|
431
Achieve Life Sciences
ACHV
$685M
| $1.12M | ﹤0.01% |
421,000
| – | – |
|
|
FRGE
432
DELISTED
Forge Global Holdings
FRGE
| $1.12M | ﹤0.01% |
+132,693
| New | +$1.53M |
|
433
Perma-Fix Environmental Services
PESI
$377M
| $1.07M | ﹤0.01% |
147,417
-552,583
| -79% | -$4.96M |
|
|
LINE
434
Lineage Inc
LINE
$9.42B
| $1.04M | ﹤0.01% |
17,697
-1,179,151
| -99% | -$68.8M |
|
435
Acumen Pharmaceuticals
ABOS
$176M
| $1.03M | ﹤0.01% |
939,603
| – | – |
|
436
Context Therapeutics
CNTX
$41.6M
| $1.02M | ﹤0.01% |
1,663,355
| – | – |
|
437
Unicycive Therapeutics
UNCY
$138M
| $1.01M | ﹤0.01% |
175,000
| – | – |
|
438
Fluor
FLR
$6.99B
| $1M | ﹤0.01% |
28,017
-1,958,078
| -99% | -$84.6M |
|
|
URG
439
Ur-Energy
URG
$564M
| $981K | ﹤0.01% |
1,454,894
-5,088,165
| -78% | -$4.99M |
|
440
Qorvo
QRVO
$8.56B
| $937K | ﹤0.01% |
12,936
+536
| +4% | +$40.8K |
|
|
PROF
441
Profound Medical
PROF
$267M
| $931K | ﹤0.01% |
160,000
| – | – |
|
|
BBNX
442
Beta Bionics
BBNX
$738M
| $918K | ﹤0.01% |
+75,000
| New | +$1.4M |
|
443
Rigetti Computing
RGTI
$5.89B
| $909K | ﹤0.01% |
+114,801
| New | +$1.27M |
|
|
SVCO
444
Silvaco Group
SVCO
$250M
| $908K | ﹤0.01% |
199,194
| – | – |
|
445
monday.com
MNDY
$3.75B
| $888K | ﹤0.01% |
+3,653
| New | +$965K |
|
|
BLD
446
DELISTED
TopBuild
BLD
| $884K | ﹤0.01% |
2,899
-44,893
| -94% | -$14.4M |
|
447
Intelligent Bio Solutions
INBS
$4.69M
| $884K | ﹤0.01% |
+61,389
| New | +$1.15M |
|
448
BiomX
PHGE
$1.78M
| $884K | ﹤0.01% |
83,723
+38,176
| +84% | +$533K |
|
449
CAMP4 Therapeutics
CAMP
$265M
| $800K | ﹤0.01% |
200,000
| – | – |
|
450
Braze
BRZE
$3.24B
| $800K | ﹤0.01% |
+22,160
| New | +$892K |
|
Similar funds
SAM
VIA
Alyeska Investment Group's Q1 2025 Portfolio in Review
As of Q1 2025, Alyeska Investment Group held 697 positions worth $25.1B, down 5.7% from $26.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Alyeska Investment Group's Q1 2025 filing shows 161 new, 139 increased, 161 reduced and 204 closed positions. Its largest new stake was Salesforce: 988,971 shares worth $265M. The largest sale was iShares Core S&P 500 ETF, an estimated $876M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Alyeska Investment Group's largest Q1 2025 buy was Salesforce: 988,971 shares worth $265M.
- Alyeska Investment Group added most to Amazon in Q1 2025, an estimated $563M increase.
- Alyeska Investment Group's biggest Q1 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $876M.
- Alyeska Investment Group fully exited Alphabet (Google) Class A in Q1 2025, selling an estimated $321M.
- Alyeska Investment Group's ten largest holdings make up 22% of its $25.1B portfolio in Q1 2025.
- Alyeska Investment Group opened 161 new positions and closed 204 in Q1 2025.
- Alyeska Investment Group's portfolio value fell 5.7% quarter-over-quarter to $25.1B.
Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.